PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Biomarker assays kits PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis: PART 06: Market segmentation by indication • AD • PD • ASD • MS PART 07: Market segmentation by application • Genomics-based biomarkers • Proteomics-based biomarkers • Metabolomics-based biomarkers • Imaging-based biomarkers • Emerging application areas PART 08: Market segmentation by services • Services PART 09: Market segmentation by end-user • Hospitals • Diagnostic and research laboratories PART 10: Geographical segmentation • Neurological biomarkers market in Americas • Neurological biomarkers market in EMEA • Neurological biomarkers market in APAC PART 11: Market drivers • Increasing low-cost clinical trials in developing countries • Growing personalized medicine for neurological disorders • Increasing focus toward drug discovery applications PART 12: Impact of drivers PART 13: Market challenges • Unmet market needs of effective validation of biomarkers • Reproducibility of biomarkers and tests leading to discrepancies • Delay in market launch PART 14: Impact of drivers and challenges PART 15: Market trends • Integrated biology approach will be the key focus area • Development of novel radiotracers for neuro biomarkers that aid diagnostic and clinical applications for diseases • Evolution of miRNA PART 16: Vendor landscape • Competitive scenario PART 17: Key vendor analysis • Geographic presence — Key vendor analysis • Myriad RBM • Proteome Sciences • QIAGEN • Thermo Fisher Scientific • Other prominent vendors PART 18: Appendix • List of abbreviations PART 19: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Key biomarker technology platforms Exhibit 03: Global neurological biomarkers market (2016-2020) ($ billions) Exhibit 04: Five forces analysis Exhibit 05: Market segmentation by indication Exhibit 06: Market opportunities in the major indications Exhibit 07: Global neurological biomarkers market segmentation by application 2015 Exhibit 08: Market opportunities in key applications Exhibit 09: Impact mapping of neurological biomarker services Exhibit 10: Opportunity analysis of biomarker services Exhibit 11: Global neurological biomarkers market 2015 Exhibit 12: Market overview in Americas 2015 Exhibit 13: Neurological biomarkers market in Americas ($ billions) Exhibit 14: Market overview in EMEA 2015 Exhibit 15: Neurological biomarkers market in EMEA ($ billions) Exhibit 16: Market overview in APAC 2015 Exhibit 17: Neurological biomarkers market in APAC ($ millions) Exhibit 18: Impact of drivers Exhibit 19: Impact of drivers and challenges Exhibit 20: Competitive structure analysis of global neurological biomarkers market 2015 Exhibit 21: Market penetration of key neurological biomarkers manufacturers 2015 Exhibit 22: Strategic success factors of companies in global neurological biomarkers market Exhibit 23: Regional analysis of key vendors Exhibit 24: Myriad RBM: Profile Exhibit 25: Myriad RBM: Strength analysis Exhibit 26: Myriad RBM: Growth strategy matrix Exhibit 27: Myriad RBM: Opportunity assessment analysis Exhibit 28: Proteome Sciences: Profile Exhibit 29: Proteome Sciences: Strength analysis Exhibit 30: Proteome Sciences: Growth strategy matrix Exhibit 31: Proteome Sciences: Opportunity assessment Exhibit 32: QIAGEN: Profile Exhibit 33: QIAGEN: Strength analysis Exhibit 34: QIAGEN: Growth strategy matrix Exhibit 35: QIAGEN: Opportunity assessment Exhibit 36: Thermo Fisher Scientific: Profile Exhibit 37: Thermo Fisher Scientific: Strength analysis Exhibit 38: Thermo Fisher Scientific: Growth strategy matrix Exhibit 39: Thermo Fisher Scientific: Growth opportunity assessment

Myriad RBM, Proteome Sciences, QIAGEN, Thermo Fisher Scientific, AbaStar MDx, Abiant, Acumen Pharmaceuticals, Aepodia, Alseres Pharmaceuticals, Athena Diagnostics, Banyan Biomarkers, Cisbio Bioassays, Diagenic, Proteosys, Psynova Neurotech.